Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kiratisin P, 2008, Molecular characterization and epidemiology of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic, Antimicrob Agents Chemother, 52, 2818, 10.1128/AAC.00171-08
Bush K, 1995, A functional classification scheme for β-lactamases and its correlation with molecular structure, Antimicrob Agents Chemother, 39, 1211, 10.1128/AAC.39.6.1211
Paterson DL, 2005, Extended-spectrum β-lactamases: a clinical update, Clin Microbiol Rev, 18, 657, 10.1128/CMR.18.4.657-686.2005
Knothe H, 1983, Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of 1Klebsiella pneumoniae and Serratia marcescens, Infect, 11, 315, 10.1007/BF01641355
Bauernfeind A, 1990, A new plasmidic cefotaximase from patients infected with Salmonella typhimorium, Infect, 20, 158, 10.1007/BF01704610
Barthélémy M, 1992, Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca, Biochim Biophys Acta, 1122, 15, 10.1016/0167-4838(92)90121-S
Bonnet R, 2004, Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes, Antimicrob Agents Chemother, 48, 1, 10.1128/AAC.48.1.1-14.2004
Paterson DL, 2003, Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type_-lactamases, Antimicrob Agents Chemother, 47, 3554, 10.1128/AAC.47.11.3554-3560.2003
Al-agamy MHM, 2006, First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt, Inter J Antimicrob Agents, 27, 545, 10.1016/j.ijantimicag.2006.01.007
Soge OO, 2006, CTX-M-15 extended-spectrum β-lactamases from Nigerian Klebsiella pneumoniae, J Antimicrob Chemother, 57, 24, 10.1093/jac/dki429
Livermore DM, 2007, CTX-M: changing the face of ESBLs in Europe, J Antimicrob Chemother, 59, 165, 10.1093/jac/dkl483
El-Khizzi NA, 2006, Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital, Saudi Med J, 27, 37
Panhotra BR, 2004, Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia Risk factors and clinical outcome, Saudi Med J, 25, 1871
Clinical and Laboratory Standards Institute, 2006, Approved standard M7-A7 CLSI, 7
Nüesch-Inderbinen MT, 1997, Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12, Antimicrob Agents Chemother, 41, 943, 10.1128/AAC.41.5.943
Bonnet R, 2001, Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240_Gly, Antimicrob Agents Chemother, 45, 2269, 10.1128/AAC.45.8.2269-2275.2001
Baraniak A, 2002, Ceftazidime-hydrolyzing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland, J Antimicrob Chemother, 50, 393, 10.1093/jac/dkf151
Villegas MV, 2004, Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals, Diagn Microbiol Infect Dis, 49, 217, 10.1016/j.diagmicrobio.2004.03.001
Chanawong A, 2002, Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China, Antimicrob Agents Chemother, 46, 630, 10.1128/AAC.46.3.630-637.2002
Bilal NE, 2001, Clinical and community strains of Klebsiella pneumoniae: multiple and increasing rates of antibiotic resistance in Abha, Saudi Arabia, Br J Biomed Sci, 57, 185
Goosens H, 2001, MYSTIC programme: summary of European data from 1997 to 2000, Diagn Microbiol Infect Dis, 41, 183, 10.1016/S0732-8893(01)00320-0
Otman J, 2002, An outbreak of extended-spectrum beta-lactamase-producing Klebsiella species in a neonatal intensive care unit in Brazil, Infect Control Hosp Epidemiol, 23, 8, 10.1086/503447
Pfaller MA, 1993, Multicenter evaluation of the antimicrobial activity for six broad-spectrum beta-lactams in Venezuela: comparison of data from 1997 and 1998 using the E test method. Venezuelan Antimicrobial Resistance Study Group, Diagn Microbiol Infect Dis, 35, 153, 10.1016/S0732-8893(99)00071-1
Sader HS, 2000, Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98), Braz J Infect Dis, 4, 245
Lewis MT, 1999, In vitro evaluation of cefepime and other broad-spectrum beta-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samples. The Japan Antimicrobial Resistance Study Group, Diagn Microbiol Infect Dis, 35, 307, 10.1016/S0732-8893(99)00120-0
Hawser SP, 2009, Emergence of High Levels of Extended-Spectrum {beta}-lactamase-producing Gram-negative Bacilli in Asia/Pacific: Data from SMART 2007, Antimicrob Agents Chemother
Shah AA, 2004, Prevalence of extended spectrum B-lactamases in nosocomial and outpatients (ambulatory), Pak J Med Sci, 19, 187
Jamal W, 2005, Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital, Med Princ Pract, 14, 325, 10.1159/000086930
Al-Zarouni M, 2008, Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates, Med Princ Pract, 17, 32, 10.1159/000109587
Shehabi AA, 2000, High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum β-lactam drugs in intensive care units, Diagn Microbiol Infect Dis, 36, 53, 10.1016/S0732-8893(99)00108-X
Goossens H, 2006, MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibility between countries and center types, J Antimicrob Chemother, 46, 39, 10.1093/jac/46.suppl_2.39
Andrews JM, 2001, BSAC working party on susceptibility testing: BSAC standardized susceptibility testing method, J Antimicrob Chemother, 48, 43, 10.1093/jac/48.suppl_1.43
Lautenbach E, 2001, Epidemiological investigation of fluoroquinolone resistance in infection due to extended-spectrum β-lactamases producing Escherichia coli and Klebsiella pneumoniae, Clin Infect Dis, 33, 1288, 10.1086/322667
Paterson DL, 2001, Rapid method of extraction and analysis of extended-spectrum β-lactamases from clinical strains of Klebsiella pneumoniae, Clin Microbiol Infect, 7, 709, 10.1046/j.1469-0691.2001.00363.x
Shahcheraghi F, 2007, Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran, Med Sci Monit, 13, BR247
Ensor VM, 2008, Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait, Int J Antimicrob Agents, 33, 487, 10.1016/j.ijantimicag.2008.10.011
Sonnevend A, 2006, CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates, Clin Microbiol Infect, 12, 582, 10.1111/j.1469-0691.2006.01413.x
Jemima SA, 2008, Multiplex PCR for bla(CTX-M) & bla(SHV) in the extended spectrum beta lactamase (ESBL) producing gram-negative isolates, Indian J Med Res, 128, 313